Activation of S6 signaling is associated with cell survival and multinucleation in hyperplastic skin after epidermal loss of AURORA-A Kinase
- 26 July 2018
- journal article
- research article
- Published by Springer Science and Business Media LLC in Cell Death & Differentiation
- Vol. 26 (3), 548-564
- https://doi.org/10.1038/s41418-018-0167-7
Abstract
The role of mitosis in the progression of precancerous skin remains poorly understood. To address this question, we deleted the mitotic Kinase Aurora-A (Aur-A) in hyperplastic mutant p53 mouse skin as an experimental tool to study the G2/M transition in precancerous keratinocytes and AUR-A’s role in this process. Epidermal Aur-A deletion (Aur-AepiΔ) led to marked keratinocyte enlargement, pleomorphism, multinucleation, and attenuated induction of cell death. This phenotype was characteristic of slippage after a stalled mitosis. We also observed altered or impaired epidermal differentiation, indicative of a partial skin barrier defect. The upregulation of mTOR/PI3K signaling was implicated as a mechanism by which keratinocytes may evade cell death after AUR-A deficiency. This was evidenced by the ectopic expression of the pathway readout, p-S6, in the basal layer of Aur-AepiΔ skin and its mitotic upregulation in isolated keratinocytes. We further tested whether our findings were extended to skin carcinoma cells. The chemical inhibition of AUR-A led to a similar mitotic delay, polyploidy/multinucleation, and attenuated cell death in skin cancer cell lines. Moreover, inhibition of mTOR/PI3K signaling ameliorated the effects caused by the deficiency of AUR-A activity but was also associated with the persistence of mitotic p-S6 detection in surviving cancer cells. These results show the induction of multinucleation/polyploidy may be a compensatory state in keratinocytes that allows for cellular survival and maintenance of partial barrier function in face of aberrant cell division or differentiation. Moreover, mTOR/PI3K signaling is active in the mitosis of hyperplastic keratinocytes expressing mutant p53 and is further enhanced by stalled mitosis, indicating a potential resistance mechanism to the use of anti-mitotic drugs in the treatment of skin cancers.Funding Information
- U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR057212, P30CA046934)
This publication has 72 references indexed in Scilit:
- PI3K/Akt-sensitive MEK-independent compensatory circuit of ERK activation in ER-positive PI3K-mutant T47D breast cancer cellsCellular Signalling, 2010
- p53 prevents progression of nevi to melanoma predominantly through cell cycle regulationPigment Cell & Melanoma Research, 2010
- TopHat: discovering splice junctions with RNA-SeqBioinformatics, 2009
- PI3-kinase-dependent activation of apoptotic machinery occurs on commitment of epidermal keratinocytes to terminal differentiationCell Research, 2008
- A quantitative atlas of mitotic phosphorylationProceedings of the National Academy of Sciences of the United States of America, 2008
- Immunolocalization of phospho-S6 kinases: a new way to detect mitosis in tissue sections and in cell cultureHistochemistry and Cell Biology, 2006
- Mitotic Checkpoint Slippage in Humans Occurs via Cyclin B Destruction in the Presence of an Active CheckpointCurrent Biology, 2006
- The chromosomal passenger complex: guiding Aurora-B through mitosisThe Journal of cell biology, 2006
- Loss of transforming growth factor-β type II receptor promotes metastatic head-and-neck squamous cell carcinomaJournal of Bone and Joint Surgery, 2006
- NF-κB blockade and oncogenic Ras trigger invasive human epidermal neoplasiaNature, 2003